Prostate Cancer
News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.
News | Radiation Therapy | June 18, 2018
June 18, 2018 — A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing...
News | Prostate Cancer | June 14, 2018
June 14, 2018 — Hitachi Medical Systems Europe has been awarded the contract to supply six ultrasound systems as part...
News | Prostate Cancer | June 13, 2018
June 13, 2018 — A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron...
News | Brachytherapy Systems | June 07, 2018
June 7, 2018 — IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate...
News | Magnetic Resonance Imaging (MRI) | May 21, 2018
May 21, 2018 — Three new studies presented at the 113th annual meeting of the American Urological Association (AUA)...
News | Radiopharmaceuticals and Tracers | May 09, 2018
Blue Earth Diagnostics Acquires Worldwide Rights to Investigational Radiohybrid PSMA-Targeted Agents
May 9, 2018 — Blue Earth Diagnostics signed an exclusive, worldwide agreement with Scintomics GmbH, Germany, a...
News | Prostate Cancer | May 09, 2018
May 9, 2018 – The U.S. Preventive Services Task Force (USPSTF) posted a final recommendation statement and evidence...
News | Prostate Cancer | April 23, 2018
April 23, 2018 — Radiotherapy given in high doses over a shorter period of time is safe and effective for prostate...
News | Prostate Cancer | March 27, 2018
March 27, 2018 — While there are many treatment options for men with prostate cancer, a recent national study published...
In scans of a 62-yr-old man with Gleason 4+3 PCa treated with radical prostatectomy, with rising PSA level (1.32) and PSA doubling time of 3.7 months, 64CuCl2-PET/CT images revealed 2 positive small left iliac lymph nodes (A,C), whereas 18F-Choline PET/CT (B,D) was negative (arrows). Image courtesy of A Piccardo et al., Galliera Hospital, Genoa, Italy.
News | Prostate Cancer | March 07, 2018
An Italian study featured in the March issue of The Journal of Nuclear Medicine demonstrates that a novel nuclear...
News | PET Imaging | February 21, 2018
February 21, 2018 — Blue Earth Diagnostics announced that Axumin (fluciclovine F 18) injection has been added to the...
68Ga-PSMA PET/CT images showing multifocal PCA in peripheral zone with GS of 5 1 5 5 10. (A and C) Axial PET images. (B and D) Fused PET/CT images. SUVmax of lesion in B was 84.3 and that of lesion in D was 5.7. IRS was 3, and 80% of cells were stained. Credit: Senior author V Prasad, Charité Universitätsmedizin Berlin, Berlin, Germany.
News | PET-CT | February 05, 2018
February 5, 2018 — Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous...
News | Prostate Cancer | December 19, 2017
December 19, 2017 — Humanetics Corp. presented data at the annual meetings of the American Society for Radiation...
News | Treatment Planning | November 14, 2017
November 14, 2017 — Spectronic Medical announced that new data for their MRIPlanner software, generating synthetic...
News | Proton Therapy | October 30, 2017
October 30, 2017 — The National Association for Proton Therapy (NAPT) announced a number of clinical papers showing...
News | Molecular Imaging | October 26, 2017
October 26, 2017 — The Netherlands Cancer Institute (NKI) announced it has received funding from the Dutch Cancer...
News | Prostate Cancer | October 17, 2017
October 17, 2017 — Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-...
News | Stereotactic Body Radiation Therapy (SBRT) | October 10, 2017
October 10, 2017 — Accuray Inc. announced that data from a prospective study of 230 men with low-risk prostate cancer...
News | Prostate Cancer | October 04, 2017
October 4, 2017 — Blue Earth Diagnostics recently announced the results of a pre-planned interim analysis from an...
News | Prostate Cancer | October 03, 2017
October 3, 2017 — A new study finds that immune response in prostate cancer may be able to forecast how patients will...
